Efficacy and Toxicity of Low-Dose Escalating Donor Lymphocyte Infusion Given After Reduced Intensity Conditioning Allograft for Multiple Myeloma

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403252
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Sezary Syndrome in Relapse After Reduced Intensity Allogeneic Transplant Successfully Treated With Donor Lymphocyte Infusion

Bone Marrow Transplantation
TransplantationHematology
2008English

Reduced Intensity Conditioning in Unrelated Donor Transplantation for Refractory Cytopenia in Childhood

Bone Marrow Transplantation
TransplantationHematology
2007English

Reduced-Intensity Conditioning for Myeloma: Lower Nonrelapse Mortality but Higher Relapse Rates Compared With Myeloablative Conditioning

Blood
BiochemistryImmunologyCell BiologyHematology
2006English

Continuous Infusion or Subcutaneous Injection of Granulocyte-Macrophage Colony-Stimulating Factor: Increased Efficacy and Reduced Toxicity When Given Subcutaneously

British Journal of Cancer
Cancer ResearchOncology
1996English

T-Cell-Depleted Allogeneic Bone Marrow Transplantation Followed by Donor Lymphocyte Infusion in Patients With Multiple Myeloma: Induction of Graft-Versus-Myeloma Effect

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Unrelated Donor Marrow (BMT) or Cord Blood Transplantation (UCBT) for Thalassemia Major After Reduced Intensity Conditioning (URTH Trial Extension)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Toxicity-Reduced, Myeloablative Allograft Followed by Lenalidomide Maintenance as Salvage Therapy for Refractory/Relapsed Myeloma Patients

Bone Marrow Transplantation
TransplantationHematology
2012English

Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications After Allogeneic Stem Cell Transplantation With Reduced-Intensity Conditioning

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Dose Intensity and the Toxicity and Efficacy of Allogeneic Hematopoietic Cell Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy